Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117892544 | 11789254 | 4 | F | 20160825 | 20151201 | 20160829 | EXP | CA-AMGEN-CANSP2015126127 | AMGEN | 65.00 | YR | E | F | Y | 0.00000 | 20160829 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117892544 | 11789254 | 1 | PS | filgrastim | FILGRASTIM | 1 | Intravenous (not otherwise specified) | UNK UNK, CYCLICAL | U | 103353 | UNKNOWN FORMULATION | ||||||||
| 117892544 | 11789254 | 2 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | UNK, CYCLICAL | U | 0 | SOLUTION FOR INJECTION | ||||||||
| 117892544 | 11789254 | 3 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 645 MG/M2, 1 IN 4 WK | 0 | 645 | MG/M**2 | SOLUTION FOR INFUSION | |||||||
| 117892544 | 11789254 | 4 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 630 MG/M2, 1 IN 3 WK | 0 | 630 | MG/M**2 | SOLUTION FOR INFUSION | Q3W | ||||||
| 117892544 | 11789254 | 5 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 840 MG/M2, 1 IN 3 WK | 0 | 840 | MG/M**2 | SOLUTION FOR INFUSION | Q3W | ||||||
| 117892544 | 11789254 | 6 | SS | RITUXIMAB | RITUXIMAB | 1 | Intravenous (not otherwise specified) | 375 MG/M2, 1 IN 3 WK | 0 | 375 | MG/M**2 | SOLUTION FOR INFUSION | Q3W | ||||||
| 117892544 | 11789254 | 7 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Intravenous (not otherwise specified) | 750 MG/M2, 1 IN 3 WK | 0 | 750 | MG/M**2 | Q3W | |||||||
| 117892544 | 11789254 | 8 | SS | DOXORUBICIN | DOXORUBICIN | 1 | Intravenous (not otherwise specified) | 50 MG/M2, 1 IN 3 WK | 0 | 50 | MG/M**2 | Q3W | |||||||
| 117892544 | 11789254 | 9 | SS | FLUDARABINE | FLUDARABINE PHOSPHATE | 1 | Unknown | UNK | 0 | ||||||||||
| 117892544 | 11789254 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | Oral | 100 MG, 1 IN 3 WK | 0 | 100 | MG | Q3W | |||||||
| 117892544 | 11789254 | 11 | SS | VINCRISTINE | VINCRISTINE | 1 | Intravenous (not otherwise specified) | 2 MG, 1 IN 3 WK | 0 | 2 | MG | Q3W | |||||||
| 117892544 | 11789254 | 12 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 117892544 | 11789254 | 13 | C | DYCLONINE HYDROCHLORIDE | DYCLONINE HYDROCHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 117892544 | 11789254 | 14 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Unknown | UNK | 0 | ||||||||||
| 117892544 | 11789254 | 15 | C | FISH OIL | FISH OIL | 1 | Unknown | UNK | 0 | CAPSULE | |||||||||
| 117892544 | 11789254 | 16 | C | PROCHLORPERAZINE. | PROCHLORPERAZINE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117892544 | 11789254 | 1 | Product used for unknown indication |
| 117892544 | 11789254 | 2 | Product used for unknown indication |
| 117892544 | 11789254 | 3 | Product used for unknown indication |
| 117892544 | 11789254 | 7 | Product used for unknown indication |
| 117892544 | 11789254 | 8 | Product used for unknown indication |
| 117892544 | 11789254 | 9 | Product used for unknown indication |
| 117892544 | 11789254 | 10 | Product used for unknown indication |
| 117892544 | 11789254 | 11 | Product used for unknown indication |
| 117892544 | 11789254 | 12 | Product used for unknown indication |
| 117892544 | 11789254 | 13 | Product used for unknown indication |
| 117892544 | 11789254 | 14 | Product used for unknown indication |
| 117892544 | 11789254 | 15 | Product used for unknown indication |
| 117892544 | 11789254 | 16 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117892544 | 11789254 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117892544 | 11789254 | Arthralgia | |
| 117892544 | 11789254 | Asthenia | |
| 117892544 | 11789254 | Blood magnesium decreased | |
| 117892544 | 11789254 | Clostridium difficile infection | |
| 117892544 | 11789254 | Disease progression | |
| 117892544 | 11789254 | Fatigue | |
| 117892544 | 11789254 | Febrile neutropenia | |
| 117892544 | 11789254 | Heart rate abnormal | |
| 117892544 | 11789254 | Hypotension | |
| 117892544 | 11789254 | Infection | |
| 117892544 | 11789254 | Lymph node pain | |
| 117892544 | 11789254 | Lymphadenitis | |
| 117892544 | 11789254 | Lymphadenopathy | |
| 117892544 | 11789254 | Malaise | |
| 117892544 | 11789254 | Muscle twitching | |
| 117892544 | 11789254 | Nausea | |
| 117892544 | 11789254 | Platelet count decreased | |
| 117892544 | 11789254 | Productive cough | |
| 117892544 | 11789254 | Pyrexia | |
| 117892544 | 11789254 | Thrombosis | |
| 117892544 | 11789254 | Weight decreased | |
| 117892544 | 11789254 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |